The United States government has delivered a shipment of long-acting injectable cabotegravir (CAB-LA) to Botswana. The donation consists of 10,125 vials and is intended for HIV prevention as pre-exposure prophylaxis. These medicines will be distributed to the Ministry of Health and provided by healthcare professionals across the country.
According to the U.S. government, this initiative aims to support Botswana in its efforts against HIV/AIDS. A statement from the announcement reads: "The U.S Government is proud to announce the arrival of a shipment of long-acting injectable cabotegravir (CAB-LA) medicines to Botswana. Donated by the American people, CAB-LA is a highly effective pre-exposure prophylaxis used for HIV prevention. The 10,125 vials will be delivered to the Ministry of Health and administered by healthcare providers throughout the country. This delivery means more lifesaving assistance for Batswana in the fight against HIV/AIDS."
Another part of the statement adds: "The U.S. is proud to stand with Botswana to make both our countries stronger, safer, and more prosperous."